1,054 research outputs found

    A review on hyperthermia via nanoparticle-mediated therapy

    Get PDF
    Hyperthermia treatment, generated by magnetic nanoparticles (MNPs) is promising since it is tumour-focused, minimally invasive and uniform. The most unique feature of magnetic nanoparticles is their reaction to and manipulation by a magnetic force which is responsible for enabling their potential as heating mediators for cancer therapy. With magnetic nanoparticle hyperthermia, a tumour is preferentially loaded with systemically administered nanoparticles with high-absorption cross section for transduction of an extrinsic energy source to heat. To maximize the energy deposited in the tumour while limiting the exposure in healthy tissues, the heating is achieved by exposing the region of tissue containing magnetic nanoparticles to an alternating magnetic field. The magnetic nanoparticles dissipate heat from relaxation losses thereby heating localized tissue above normal physiological ranges. Besides thermal efficiency, the biocompatibility of magnetite nanoparticles assists in their deployment as efficient drug carriers for targeted therapeutic regimes. In the present article we provide a state-of-the-art review focused on progress in nanoparticle induced hyperthermia treatments which have several potential advantages over both global and local hyperthermia treatments achieved without nanoparticles. Green bio-nanotechnology has attracted substantial attention and has demonstrable abilities to improve cancer therapy. Furthermore we have listed the challenges associated with this treatment along with future opportunities in this field which it is envisaged will be of interest to biomedical engineers, bio-materials scientists, medical researchers and pharmacological research groups

    An assessment of industry position on shared equity housing model development in the UK

    Get PDF
    This paper investigated affordable housing problems and how they impact the development of Shared Equity Housing Models (SEHM) with emphasis on the Community Land Trust (CLT). The methodological approach identified and tackled inherent industry sources of barriers to Community Land Trust Shared Equity Housing Models (CLT SEHM) development through literature reviews and the text analysis of semi-structured interview responses from key stakeholders. Findings indicated that industry sources of barriers to CLT development occur within crucial bilateral dimensions impacting its capabilities as an adoptable model for major housing providers, and for local practitioners in well-defined communes for localised housing. This study opens a further debate on the downsides of the current housing delivery arrangement, and the need for an improved capacity for innovation through more sustainable alternatives/policies - particularly in a sector dominated by tested mainstream options, however with performance and affordability inconsistencies ā€“ in UK housing development. Keywords: housing; affordable housing; industry; shared equity housing models; SEHM; community land trust; CL

    Weight reduction with improvement of serum lipid profile and ratios of Sesamum radiatum leaves diet in a non-obese Sprague Dawley rats

    Get PDF
    Development of novel natural dietary adjunct/agent with significant therapeutic effects on metabolic disease conditions such as obesity and heart disease raises concern in recent times. We studiedchronic toxicity of the combined active ingredients present in the sesame leaves and their interaction on the fasting serum lipid profiles with their ratios in thirty adult male non-obese Sprague Dawley (SD)rats. Such that, both treated groups received 14.0 and 28.0 mg/kg body weight doses of aqueous leaves extract of Sesamum radiatum respectively on a daily basis via gastric gavage, while, the controlreceived equal volume of normal saline daily for six weeks. Significant (P < 0.05) weight loss observed in the treated groups was associated with significant (P < 0.05) reductions in both serum cholesteroland triglycerides (TG). The effect on the serum lipoprotein cholesterol components and ratios were significant in a dose related manner, such that increase in HDL accompanied a corresponding decreasein both LDL and LDL/HDL ratio. In addition, to increased in TG/HDL ratio. However, no significant differences in the relative reduction level of VLDL and triglycerides in the treated groups were found compared to control. Thus, LDL/HDL ratio is significantly a better indicator than the TG/HDL ratio in assessing the impact of sesame treatment with evidence of weight loss and hypolipidaemia especially in hypertensive heart diseases

    Relationship between age, radiographic normal heart size and cardio-thoracic ratio in a Nigerian population

    Get PDF
    Background: Cardio-vascular disease (CVD) is now on the increase. The precise diagnosisĀ of CVD is of immense clinical importance to the cardiac surgeons, pathologist and alsoĀ for cardiologists. However, information on normal values for various cardio-vascularĀ structures in Nigeria, a country with the highest population of blacks in the world isĀ sparse. In this regard the age-related radiographic sizes of a Nigerian cohort of patientsĀ with non-cardiogenic complaints or consultations were therefore assessed.Objectives: To evaluate the limits of normal cardiac size in our environment , determineĀ if there was a relationship between the age and size of the heart and to evaluate theĀ relationship between sex and cardiac size and cardio-thoracic ratio.Design: A cross-sectional study.Setting: The Radiology department of University of Ilorin Teaching Hospital, Ilorin,Ā North Central Nigeria between January to June 2012.Subjects: One Hundred patients were consecutively recruited and their chest radiographsĀ examined after fulfilling the inclusion criteria.Results: Males accounted for 55% of the study population. The age range was 1 monthĀ to 73 years, (Mean = 29.3, SD =2.41668). The mean cardiac size was 11.7cm. The averageĀ cardiac size for adult males and females, were 11.6cm and 11.5cm respectively whileĀ that of thoracic size was 29.0cm and 26.8cm respectively. Correlation between ageĀ and cardiac size was 0.66; age and thoracic size was 0.64 and between cardiac size andĀ thoracic size was 0.89. The paired sample t-test for age and cardiac size was less thanĀ 0.05 (p value &lt;0.05).Conclusion: knowing the average values of cardiac size for adult males and femalesĀ (11.6cm and 11.5cm) and thoracic size (29.0cm and 26.8cm) respectively from this studyĀ presents a base line for early detection of variation from normal cardiac measurementsĀ in this environment

    Modeling magnetic nanopolymer flow with induction and nanoparticle solid volume fraction effects : solar magnetic nanopolymer fabrication simulation

    Get PDF
    A mathematical model is presented for the nonlinear steady, forced convection, hydromagnetic flow of electro-conductive magnetic nano-polymer with magnetic induction effects included. The transformed two-parameter, non-dimensional governing partial differential equations for mass, momentum, magnetic induction and heat conservation are solved with the local non-similarity method (LNM) subject to appropriate boundary conditions. Kellerā€™s implicit finite difference ā€œboxā€ method (KBM) is used to validate solutions. Computations for four different nanoparticles and three different base fluids are included. Silver nanoparticles in combination with various base fluids enhance temperatures and induced magnetic field and accelerate the flow. An elevation in magnetic body force number decelerates the flow whereas an increase in magnetic Prandtl number elevates the magnetic induction. Furthermore, increasing nanoparticle solid volume fraction is found to substantially boost temperatures. Applications of the study arise in advanced magnetic solar nano-materials (fluids) processing technologies

    Synergistic Antimicrobial Activities Of Phytoestrogens In Crude Extracts Of Two Sesame Species Against Some Common Pathogenic Microorganisms

    Get PDF
    Intensive studies on extracts and biologically active compounds isolated from medicinal plants have doubled in the last decade worldwide. However, as a result of paucity of knowledge and folkloric claim on the effectiveness of sesame leaves in infectious disease treatments, we aimed to determine the synergistic antimicrobial activity of essential oils and lignans present in the crude leaves extracts of Sesame radiatum and Sesame indicum. Ethanolic, methanolic and aqueous extracts of both leaves were studied for their in-vitro synergistic antimicrobial activity against both Gram positive and Gram negative micro-organisms, and Yeast using Agar diffusion method. The GC-MS phytochemical screening of methanolic extract showed that the major compounds in essential oils are of carboxylic acids and phenolic groups especially, the most potent antioxidants known to man like sesamol, sesamolin and sesamin among others. Methanolic and ethanolic extracts have broad spectrum antimicrobial effect against all the tested pathogenic micro-organisms except Streptococcus pneumoniae and Staphylococcus aureus respectively, while the aqueous extract exhibited inhibitory activity on Staphylococcus aureus, Streptococcus pneumoniae and Candida albicans. The result confirmed the folkloric claims of the antimicrobial effectiveness of locally consumed sesame leaves extracts especially against bacterial and common skin infection in many areas of Nigeria . Keywords: Pathogenic micro-organisms, Gram-positive, Gram-negative,Yeast, Anti-microbial, Sesame leaves, GC-MS, MICAfrican Journal of Traditional and Complementary Medicine Vol. 4 (4) 2007: pp. 427-43

    Differential effects of bile acids on the postprandial secretion of gut hormones: a randomized crossover study.

    Get PDF
    Bile acids (BA) regulate postprandial metabolism directly and indirectly by affecting the secretion of gut hormones like glucagon-like peptide-1 (GLP-1). The postprandial effects of BA on the secretion of other metabolically active hormones are not well understood. The objective of this study was to investigate the effects of oral ursodeoxycholic acid (UDCA) and chenodeoxycholic acid (CDCA) on postprandial secretion of GLP-1, oxyntomodulin (OXM), peptide YY (PYY), glucose-dependent insulinotropic peptide (GIP), glucagon, and ghrelin. Twelve healthy volunteers underwent a mixed meal test 60ā€‰min after ingestion of UDCA (12-16ā€‰mg/kg), CDCA (13-16ā€‰mg/kg), or no BA in a randomized crossover study. Glucose, insulin, GLP-1, OXM, PYY, GIP, glucagon, ghrelin, and fibroblast growth factor 19 were measured prior to BA administration at -60 and 0 min (just prior to mixed meal) and 15, 30, 60, 120, 180, and 240ā€‰min after the meal. UDCA and CDCA provoked differential gut hormone responses; UDCA did not have any significant effects, but CDCA provoked significant increases in GLP-1 and OXM and a profound reduction in GIP. CDCA increased fasting GLP-1 and OXM secretion in parallel with an increase in insulin. On the other hand, CDCA reduced postprandial secretion of GIP, with an associated reduction in postprandial insulin secretion. Exogenous CDCA can exert multiple salutary effects on the secretion of gut hormones; if these effects are confirmed in obesity and type 2 diabetes, CDCA may be a potential therapy for these conditions. NEW & NOTEWORTHY: Oral CDCA and UDCA have different effects on gut and pancreatic hormone secretion. A single dose of CDCA increased fasting secretion of the hormones GLP-1 and OXM with an accompanying increase in insulin secretion. CDCA also reduced postprandial GIP secretion, which was associated with reduced insulin. In contrast, UDCA did not change gut hormone secretion fasting or postprandially. Oral CDCA could be beneficial to patients with obesity and diabetes

    Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

    Get PDF
    Background: Casirivimab and imdevimab are non-competing monoclonal antibodies that bind to two different sites on the receptor binding domain of the SARS-CoV-2 spike glycoprotein, blocking viral entry into host cells. We aimed to evaluate the efficacy and safety of casirivimab and imdevimab administered in combination in patients admitted to hospital with COVID-19. Methods: RECOVERY is a randomised, controlled, open-label platform trial comparing several possible treatments with usual care in patients admitted to hospital with COVID-19. 127 UK hospitals took part in the evaluation of casirivimab and imdevimab. Eligible participants were any patients aged at least 12 years admitted to hospital with clinically suspected or laboratory-confirmed SARS-CoV-2 infection. Participants were randomly assigned (1:1) to either usual standard of care alone or usual care plus casirivimab 4 g and imdevimab 4 g administered together in a single intravenous infusion. Investigators and data assessors were masked to analyses of the outcome data during the trial. The primary outcome was 28-day all-cause mortality assessed by intention to treat, first only in patients without detectable antibodies to SARS-CoV-2 infection at randomisation (ie, those who were seronegative) and then in the overall population. Safety was assessed in all participants who received casirivimab and imdevimab. The trial is registered with ISRCTN (50189673) and ClinicalTrials.gov (NCT04381936). Findings: Between Sept 18, 2020, and May 22, 2021, 9785 patients enrolled in RECOVERY were eligible for casirivimab and imdevimab, of which 4839 were randomly assigned to casirivimab and imdevimab plus usual care and 4946 to usual care alone. 3153 (32%) of 9785 patients were seronegative, 5272 (54%) were seropositive, and 1360 (14%) had unknown baseline antibody status. 812 (8%) patients were known to have received at least one dose of a SARS-CoV-2 vaccine. In the primary efficacy population of seronegative patients, 396 (24%) of 1633 patients allocated to casirivimab and imdevimab versus 452 (30%) of 1520 patients allocated to usual care died within 28 days (rate ratio [RR] 0Ā·79, 95% CI 0Ā·69ā€“0Ā·91; p=0Ā·0009). In an analysis of all randomly assigned patients (regardless of baseline antibody status), 943 (19%) of 4839 patients allocated to casirivimab and imdevimab versus 1029 (21%) of 4946 patients allocated to usual care died within 28 days (RR 0Ā·94, 95% CI 0Ā·86ā€“1Ā·02; p=0Ā·14). The proportional effect of casirivimab and imdevimab on mortality differed significantly between seropositive and seronegative patients (p value for heterogeneity=0Ā·002). There were no deaths attributed to the treatment, or meaningful between-group differences in the pre-specified safety outcomes of cause-specific mortality, cardiac arrhythmia, thrombosis, or major bleeding events. Serious adverse reactions reported in seven (<1%) participants were believed by the local investigator to be related to treatment with casirivimab and imdevimab. Interpretation: In patients admitted to hospital with COVID-19, the monoclonal antibody combination of casirivimab and imdevimab reduced 28-day mortality in patients who were seronegative (and therefore had not mounted their own humoral immune response) at baseline but not in those who were seropositive at baseline. Funding: UK Research and Innovation (Medical Research Council) and National Institute of Health Research

    High concentration of childhood deaths in the low-lying areas of Chakaria HDSS, Bangladesh: findings from a spatial analysis

    Get PDF
    Background: Despite significant reduction of childhood mortality in Bangladesh, large spatial variations persist. Identification of lower level spatial units with higher concentrations of deaths can be useful for strengthening services in these areas. This paper reports findings from a spatial analysis of deaths in Chakaria, a rural subdistrict, where a Health and Demographic Surveillance System has been in place since 1999. Chakaria is an INDEPTH member site. Methods: An analysis was done of 339 deaths among nearly 24,500 children under the age of five during 2005&#x2013;2008. One ward, the lowest level of administrative units, was the unit of spatial analysis. Data from 24 wards were analyzed. The Discrete Poisson Probability Model was used to identify the clustering of deaths. Results: Deaths were concentrated within 12 wards located in the low-lying deltaic flood plains of the Chakaria HDSS area. The risk of death in the low-lying areas was statistically, significantly higher, 1.5 times, than the non-low-lying areas (p&#60;0.02). Conclusion: Spatial analysis can be a useful tool for identifying high-risk mortality areas. An understanding of the risk factors prevalent in the low-lying areas can help design effective interventions to reduce mortality in these areas
    • ā€¦
    corecore